{"count": 54, "results": [{"_id": "37502816", "pmid": 37502816, "pmcid": "PMC10370497", "title": "The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression", "journal": "Front Psychiatry", "authors": ["Battini V", "Cirnigliaro G", "Leuzzi R", "Rissotto E", "Mosini G", "Benatti B", "Pozzi M", "Nobile M", "Radice S", "Carnovale C", "Dell'Osso B", "Clementi E"], "date": "2023-07-12T00:00:00Z", "doi": "10.3389/fpsyt.2023.1215807", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1215807", "score": 50268.65, "text_hl": "Our aim is to whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as add-on therapy improved or not @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@SCZ@@@ symptoms, with a particular interest in cognitive functions. ", "citations": {"NLM": "Battini V, Cirnigliaro G, Leuzzi R, Rissotto E, Mosini G, Benatti B, Pozzi M, Nobile M, Radice S, Carnovale C, Dell'Osso B, Clementi E. The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression Front Psychiatry. 2023;14():1215807. PMID: 37502816", "BibTeX": "@article{37502816, title={The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression}, author={Battini V and Cirnigliaro G and Leuzzi R and Rissotto E and Mosini G and Benatti B and Pozzi M and Nobile M and Radice S and Carnovale C and Dell'Osso B and Clementi E}, journal={Front Psychiatry}, volume={14}, pages={1215807}}"}}, {"_id": "34658963", "pmid": 34658963, "pmcid": "PMC8511431", "title": "Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials", "journal": "Front Psychiatry", "authors": ["Zhang L", "Qi H", "Xie YY", "Zheng W", "Liu XH", "Cai DB", "Ng CH", "Ungvari GS", "Xiang YT"], "date": "2021-09-29T00:00:00Z", "doi": "10.3389/fpsyt.2021.728204", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "728204", "score": 50264.62, "text_hl": "RCTs that used @CHEMICAL_Aripiprazole @CHEMICAL_MESH:D000068180 @@@aripiprazole@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, or PGD as the primary medications for @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@schizophrenia@@@ were excluded.", "citations": {"NLM": "Zhang L, Qi H, Xie YY, Zheng W, Liu XH, Cai DB, Ng CH, Ungvari GS, Xiang YT. Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials Front Psychiatry. 2021;12():728204. PMID: 34658963", "BibTeX": "@article{34658963, title={Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials}, author={Zhang L and Qi H and Xie YY and Zheng W and Liu XH and Cai DB and Ng CH and Ungvari GS and Xiang YT}, journal={Front Psychiatry}, volume={12}, pages={728204}}"}}, {"_id": "36816406", "pmid": 36816406, "pmcid": "PMC9933920", "title": "Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study", "journal": "Front Psychiatry", "authors": ["Liu X", "Sun X", "Li L", "Zeng K", "Li Y", "Gao Y", "Ma J"], "date": "2023-02-02T00:00:00Z", "doi": "10.3389/fpsyt.2023.1124691", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1124691", "score": 50264.266, "text_hl": "In our study, the conventional @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose (1-2 g/day) used to treat @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ in @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@schizophrenia@@@ with co-morbid T2DM also had the same function of lowering @GENE_PRL @GENE_5617 @@@PRL@@@ levels and showed a negative dose-dependence of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose and @GENE_PRL @GENE_5617 @@@PRL@@@ levels. ", "citations": {"NLM": "Liu X, Sun X, Li L, Zeng K, Li Y, Gao Y, Ma J. Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study Front Psychiatry. 2023;14():1124691. PMID: 36816406", "BibTeX": "@article{36816406, title={Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study}, author={Liu X and Sun X and Li L and Zeng K and Li Y and Gao Y and Ma J}, journal={Front Psychiatry}, volume={14}, pages={1124691}}"}}, {"_id": "32581680", "pmid": 32581680, "pmcid": "PMC7283619", "title": "Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model", "journal": "Front Neurosci", "authors": ["Zhou C", "Kong D", "Xue R", "Chen M", "Li G", "Xu Y", "Liu S", "Tian H", "Zhuo C"], "date": "2020-06-03T00:00:00Z", "doi": "10.3389/fnins.2020.00517", "meta_date_publication": "2020", "meta_volume": "14", "meta_issue": "", "meta_pages": "517", "score": 50253.348, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Enhances Antidepressant/Antipsychotic Combination Therapy of @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@Schizophrenia@@@ With Comorbid @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@Depression@@@ in a @SPECIES_10090 @@@Murine@@@ Model", "citations": {"NLM": "Zhou C, Kong D, Xue R, Chen M, Li G, Xu Y, Liu S, Tian H, Zhuo C. Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model Front Neurosci. 2020;14():517. PMID: 32581680", "BibTeX": "@article{32581680, title={Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model}, author={Zhou C and Kong D and Xue R and Chen M and Li G and Xu Y and Liu S and Tian H and Zhuo C}, journal={Front Neurosci}, volume={14}, pages={517}}"}}, {"_id": "37821461", "pmid": 37821461, "pmcid": "PMC10567690", "title": "Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex", "journal": "Transl Psychiatry", "authors": ["Shao T", "Huang J", "Zhao Y", "Wang W", "Tian X", "Hei G", "Kang D", "Gao Y", "Liu F", "Zhao J", "Liu B", "Yuan TF", "Wu R"], "date": "2023-10-11T00:00:00Z", "doi": "10.1038/s41398-023-02616-x", "meta_date_publication": "2023 Oct 11", "meta_volume": "13", "meta_issue": "1", "meta_pages": "315", "score": 50251.164, "text_hl": "The present study found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ effectively improves cognition in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@schizophrenia@@@. ", "citations": {"NLM": "Shao T, Huang J, Zhao Y, Wang W, Tian X, Hei G, Kang D, Gao Y, Liu F, Zhao J, Liu B, Yuan TF, Wu R. Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex Transl Psychiatry. 2023 Oct 11;13(1):315. PMID: 37821461", "BibTeX": "@article{37821461, title={Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex}, author={Shao T and Huang J and Zhao Y and Wang W and Tian X and Hei G and Kang D and Gao Y and Liu F and Zhao J and Liu B and Yuan TF and Wu R}, journal={Transl Psychiatry}, volume={13}, number={1}, pages={315}}"}}, {"_id": "32588080", "pmid": 32588080, "title": "Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats.", "journal": "Psychopharmacology (Berl)", "authors": ["Luo C", "Wang X", "Mao X", "Huang H", "Liu Y", "Zhao J", "Zhou H", "Liu Z", "Li X"], "date": "2020-08-01T00:00:00Z", "doi": "10.1007/s00213-020-05524-w", "meta_date_publication": "2020 Aug", "meta_volume": "237", "meta_issue": "8", "meta_pages": "2257-2277", "score": 50249.992, "text_hl": "Whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can reverse @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@AIMD@@@ and whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ affects the therapeutic effects of antipsychotics in animal models of @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@schizophrenia@@@ are questions that still need to be investigated. ", "citations": {"NLM": "Luo C, Wang X, Mao X, Huang H, Liu Y, Zhao J, Zhou H, Liu Z, Li X. Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats. Psychopharmacology (Berl). 2020 Aug;237(8):2257-2277. PMID: 32588080", "BibTeX": "@article{32588080, title={Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats.}, author={Luo C and Wang X and Mao X and Huang H and Liu Y and Zhao J and Zhou H and Liu Z and Li X}, journal={Psychopharmacology (Berl)}, volume={237}, number={8}, pages={2257-2277}}"}}, {"_id": "40649798", "pmid": 40649798, "title": "Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model.", "journal": "Int J Mol Sci", "authors": ["Horvath G", "Plesz SB", "Ducza E", "Varga D", "Szucs E", "Benyhe S", "Adlan LG", "Braunitzer G", "Kekesi G"], "date": "2025-06-23T00:00:00Z", "doi": "10.3390/ijms26136019", "meta_date_publication": "2025 Jun 23", "meta_volume": "26", "meta_issue": "13", "meta_pages": "", "score": 50249.16, "text_hl": "Repurposing @CHEMICAL_Caffeine @CHEMICAL_MESH:D002110 @@@Caffeine@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, and @CHEMICAL_Furosemide @CHEMICAL_MESH:D005665 @@@Furosemide@@@ to Target @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@Schizophrenia@@@-Related Impairments in a Triple-Hit @SPECIES_10116 @@@Rat@@@ Model.", "citations": {"NLM": "Horvath G, Plesz SB, Ducza E, Varga D, Szucs E, Benyhe S, Adlan LG, Braunitzer G, Kekesi G. Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model. Int J Mol Sci. 2025 Jun 23;26(13):. PMID: 40649798", "BibTeX": "@article{40649798, title={Repurposing Caffeine, Metformin, and Furosemide to Target Schizophrenia-Related Impairments in a Triple-Hit Rat Model.}, author={Horvath G and Plesz SB and Ducza E and Varga D and Szucs E and Benyhe S and Adlan LG and Braunitzer G and Kekesi G}, journal={Int J Mol Sci}, volume={26}, number={13}}"}}, {"_id": "32327628", "pmid": 32327628, "pmcid": "PMC7181777", "title": "Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials", "journal": "Transl Psychiatry", "authors": ["Jiang WL", "Cai DB", "Yin F", "Zhang L", "Zhao XW", "He J", "Ng CH", "Ungvari GS", "Sim K", "Hu ML", "Zheng W", "Xiang YT"], "date": "2020-04-23T00:00:00Z", "doi": "10.1038/s41398-020-0785-y", "meta_date_publication": "2020 Apr 23", "meta_volume": "10", "meta_issue": "1", "meta_pages": "117", "score": 50249.008, "text_hl": "Twelve studies with 1215 @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@schizophrenia@@@ @SPECIES_9606 @@@patients@@@ (592 in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group and 623 in placebo group) were included and analyzed. ", "citations": {"NLM": "Jiang WL, Cai DB, Yin F, Zhang L, Zhao XW, He J, Ng CH, Ungvari GS, Sim K, Hu ML, Zheng W, Xiang YT. Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials Transl Psychiatry. 2020 Apr 23;10(1):117. PMID: 32327628", "BibTeX": "@article{32327628, title={Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials}, author={Jiang WL and Cai DB and Yin F and Zhang L and Zhao XW and He J and Ng CH and Ungvari GS and Sim K and Hu ML and Zheng W and Xiang YT}, journal={Transl Psychiatry}, volume={10}, number={1}, pages={117}}"}}, {"_id": "32141403", "pmid": 32141403, "title": "Risk of schizophrenia in patients with polycystic ovary syndrome: a nationwide population-based cohort study from Taiwan.", "journal": "J Psychosom Obstet Gynaecol", "authors": ["Chen SF", "Yang YC", "Hsu CY", "Shen YC"], "date": "2021-12-01T00:00:00Z", "doi": "10.1080/0167482X.2020.1735342", "meta_date_publication": "2021 Dec", "meta_volume": "42", "meta_issue": "4", "meta_pages": "272-278", "score": 50248.445, "text_hl": "After adjusting for above-mentioned covariates, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment had a protective effect against the incident @<m>DISEASE_Schizophrenia</m> @DISEASE_MESH:D012559 @@@schizophrenia@@@ compared to non-users (HR: 0.16, 95% CI: 0.06-0.41). ", "citations": {"NLM": "Chen SF, Yang YC, Hsu CY, Shen YC. Risk of schizophrenia in patients with polycystic ovary syndrome: a nationwide population-based cohort study from Taiwan. J Psychosom Obstet Gynaecol. 2021 Dec;42(4):272-278. PMID: 32141403", "BibTeX": "@article{32141403, title={Risk of schizophrenia in patients with polycystic ovary syndrome: a nationwide population-based cohort study from Taiwan.}, author={Chen SF and Yang YC and Hsu CY and Shen YC}, journal={J Psychosom Obstet Gynaecol}, volume={42}, number={4}, pages={272-278}}"}}, {"_id": "37668313", "pmid": 37668313, "title": "Metformin Prescription for U.S. Veterans with Prediabetes, 2010-2019.", "journal": "J Investig Med", "authors": ["Gulanski B", "Goulet J", "Radhakrishnan K", "Ko J", "Li Y", "Rajeevan N", "Lee KM", "Heberer K", "Lynch J", "Streja E", "Mutalik P", "Cheung KH", "Concato J", "Shih MC", "Lee J", "Aslan M"], "date": "2023-09-05T00:00:00Z", "doi": "10.1177/10815589231201141", "meta_date_publication": "2023 Sep 5", "meta_volume": "", "meta_issue": "", "meta_pages": "10815589231201141", "score": 50248.344, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Prescription for U.S. ", "citations": {"NLM": "Gulanski B, Goulet J, Radhakrishnan K, Ko J, Li Y, Rajeevan N, Lee KM, Heberer K, Lynch J, Streja E, Mutalik P, Cheung KH, Concato J, Shih MC, Lee J, Aslan M. Metformin Prescription for U.S. Veterans with Prediabetes, 2010-2019. J Investig Med. 2023 Sep 5;():10815589231201141. PMID: 37668313", "BibTeX": "@article{37668313, title={Metformin Prescription for U.S. Veterans with Prediabetes, 2010-2019.}, author={Gulanski B and Goulet J and Radhakrishnan K and Ko J and Li Y and Rajeevan N and Lee KM and Heberer K and Lynch J and Streja E and Mutalik P and Cheung KH and Concato J and Shih MC and Lee J and Aslan M}, journal={J Investig Med}, pages={10815589231201141}}"}}]}